Possible association between HLA-DR5 and superficial spreading melanoma (SSM)
- 1 December 1984
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 34 (6) , 751-755
- https://doi.org/10.1002/ijc.2910340603
Abstract
Previous analyses of possible associations between MHC determinants and cutaneous malignant melanoma (MM) have been inconclusive. We have investigated 98 patients with special emphasis on histologically determined subtypes of MM, and 5 multiple‐case families. In addition to HLA‐ABC and DR typing, complement allotypes of C2, C4A, C4B, BF were determined. Among the unrelated patients HLA‐DR5 and, secondarily, B49 were observed to be associated with superficial spreading (SSM) but not with nodular (NM) or lentigo maligna melanoma (LMM). In families with MM, no definite segregation of the disease according to HLA and complement haplotypes was discernible. Moreover, no coincidence of haplotypes occurred in patients of the different families. HLA region recombinations including B/DR and/or DR/GLO were found in all the families investigated.This publication has 18 references indexed in Scilit:
- HLA-DR Antigen Expression in Primary Melanomas of the SkinJournal of Investigative Dermatology, 1984
- The pattern of the mononuclear infiltrate as a prognostic parameter in flat superficial spreading melanomasZeitschrift für Krebsforschung und Klinische Onkologie, 1984
- A review of hereditary malignant melanoma including biomarkers in familial atypical multiple mole melanoma syndromeCancer Genetics and Cytogenetics, 1983
- HLA and complement allotypes in Type 1 (insulin-dependent) diabetesDiabetologia, 1983
- Evidence for linkage between HLA and malignant melanomaTissue Antigens, 1981
- Inherited structural polymorphism of the fourth component of human complement.Proceedings of the National Academy of Sciences, 1980
- Improved B Cell Typing for HLA—DR Using Nylon Wool Column Enriched B Lymphocyte PreparationsTissue Antigens, 1979
- Inherited structural polymorphism in human C2: evidence for genetic linkage between C2 and Bf.The Journal of Experimental Medicine, 1976
- HL-A and ABO antigens and malignant melanoma.A study of 212 casesCancer, 1974
- GENETIC POLYMORPHISM IN HUMAN GLYCINE-RICH BETA-GLYCOPROTEINThe Journal of Experimental Medicine, 1972